Company · CIK 0001429560 · SIC 2834 — Pharmaceutical Preparations
TREVENA INC · TRVN
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 1, 2019 PForm 4 → | Feb 5, 4:59 pm EST | Maxine GowenPresident & CEO, Director | 50,000 | $1.02 | $51,000 | 54,000 | +1,250% | plan? |
| Feb 1, 2019 AForm 4 → | Feb 5, 8:41 am EST | Carrie L. BourdowPresident and CEO, Director | 50,000 | $1.02 | $51,000 | 304,500 | — | plan? |
| Feb 1, 2019 PForm 4 → | Feb 4, 9:01 am EST | Leon O Moulder Jr.Director | 100,000 | $1.02 | $102,000 | 100,000 | — | plan? |
| Dec 6, 2018 AForm 4 → | Dec 10, 5:04 pm EST | Robert T YoderSr. VP, Chief Business Officer | 100,000 | — | — | 100,000 | — | plan? |
| Dec 6, 2018 AForm 4 → | Dec 10, 4:49 pm EST | John P. HamillVP Fin,Princ Fin&Acct Officer | 80,000 | — | — | 80,250 | — | plan? |
| Dec 6, 2018 AForm 4 → | Dec 7, 4:40 pm EST | Mark DemitrackSr VP & Chief Medical Officer | 125,000 | — | — | 125,000 | — | plan? |
| Dec 6, 2018 AForm 4 → | Dec 7, 4:39 pm EST | Carrie L. BourdowPresident and CEO, Director | 250,000 | — | — | 254,500 | — | plan? |
| Mar 22, 2018 SForm 4 → | Mar 23, 5:16 pm EDT | Yacoub HabibSVP, Bus Dev & Corp Planning | 5,000 | $1.76 | $8,800 | 0 | −100% | plan? |
| Feb 23, 2017 MForm 4 → | Feb 27, 8:34 am EST | Maxine GowenPresident & CEO, Director | 110,403 | $0.682 | $75,295 | 126,903 | — | plan? |
| Feb 10, 2017 SForm 4 → | Feb 14, 5:20 pm EST | Michael W. LarkSr. VP, Research & CSO | 23,699 | $8.00 | $189,592 | 74,761 | −24.1% | plan? |
| Feb 10, 2017 MForm 4 → | Feb 14, 5:20 pm EST | Michael W. LarkSr. VP, Research & CSO | 12,815 | $0.682 | $8,740 | 98,460 | — | plan? |
| Jan 6, 2017 GForm 4 → | Jun 9, 5:57 pm EDT | Maxine GowenPresident & CEO, Director | 545,806 | — | — | 195,512 | — | plan? late |
| Nov 9, 2016 PForm 4 → | Nov 10, 6:12 pm EST | Carrie L. BourdowSVP, Chief Commercial Officer | 4,000 | $4.34 | $17,360 | 4,500 | +800% | plan? |
| Nov 7, 2016 PForm 4 → | Nov 9, 5:37 pm EST | Maxine GowenPresident & CEO, Director | 12,500 | $4.10 | $51,250 | 16,500 | +313% | plan? |
| Nov 7, 2016 PForm 4 → | Nov 9, 5:36 pm EST | Yacoub HabibSVP, Bus Dev & Corp Planning | 5,000 | $4.12 | $20,600 | 5,000 | — | plan? |
| Oct 20, 2016 GForm 4 → | Oct 25, 5:28 pm EDT | Maxine GowenPresident & CEO, Director | 28,168 | — | — | 139,109 | — | plan? late |
| Sep 29, 2016 GForm 4 → | Oct 19, 4:43 pm EDT | Maxine GowenPresident & CEO, Director | 550,050 | — | — | 144,000 | — | plan? late |
| May 26, 2016 PForm 4 → | May 31, 5:34 pm EDT | Maxine GowenPresident & CEO, Director | 22,084 | $7.12 | $157,275 | 293,109 | +8.15% | plan? |
| Dec 10, 2015 SForm 4 → | Dec 11, 5:17 pm EST | David SoergelSr. VP,Clinical Dev. & CMO | 27,217 | $10.55 | $287,139 | 1,750 | −94.0% | plan? |
| Dec 9, 2015 JForm 4 → | Dec 10, 12:19 pm EST | Jason Raleigh NunnDirector | 4,271 | — | — | 4,271 | — | plan? |
| Feb 20, 2015 GForm 4 → | Mar 19, 5:14 pm EDT | Maxine GowenPresident & CEO, Director | 51,000 | — | — | 275,025 | — | plan? late |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 6, 2018 AForm 4 → | Dec 10, 5:04 pm EST | Robert T YoderSr. VP, Chief Business Officer | 100,000 | — | — | 100,000 | — | |
| Dec 6, 2018 AForm 4 → | Dec 7, 4:40 pm EST | Mark DemitrackSr VP & Chief Medical Officer | 125,000 | — | — | 125,000 | — | |
| Dec 6, 2018 AForm 4 → | Dec 7, 4:39 pm EST | Carrie L. BourdowPresident and CEO, Director | 250,000 | — | — | 250,000 | — | |
| Sep 27, 2018 AForm 4 → | Oct 1, 4:22 pm EDT | Carrie L. BourdowPresident and CEO, Director | 335,000 | — | — | 335,000 | — | |
| Sep 27, 2018 AForm 4 → | Oct 1, 4:21 pm EDT | Scott BraunsteinDirector | 60,000 | — | — | 60,000 | — | |
| Aug 31, 2018 AForm 4 → | Sep 4, 4:57 pm EDT | John P. HamillVP Fin,Princ Fin&Acct Officer | 52,500 | — | — | 52,500 | — | |
| May 21, 2018 AForm 4 → | May 23, 5:04 pm EDT | Mark DemitrackSr VP & Chief Medical Officer | 200,000 | — | — | 200,000 | — | |
| May 16, 2018 AForm 4 → | May 17, 5:38 pm EDT | Jason Raleigh NunnDirector | 30,000 | — | — | 30,000 | — | |
| May 16, 2018 AForm 4 → | May 17, 5:11 pm EDT | Barbara YanniDirector | 30,000 | — | — | 30,000 | — | |
| May 16, 2018 AForm 4 → | May 17, 5:10 pm EDT | Anne M. PhillipsDirector | 30,000 | — | — | 30,000 | — | |
| May 16, 2018 AForm 4 → | May 17, 5:10 pm EDT | Adam KoppelDirector | 30,000 | — | — | 30,000 | — | |
| May 16, 2018 AForm 4 → | May 17, 5:09 pm EDT | Michael R DoughertyDirector | 30,000 | — | — | 30,000 | — | |
| May 16, 2018 AForm 4 → | May 17, 5:08 pm EDT | Leon O Moulder Jr.Director | 30,000 | — | — | 30,000 | — | |
| May 16, 2018 AForm 4 → | May 17, 5:07 pm EDT | Julie McHughDirector | 30,000 | — | — | 30,000 | — | |
| Feb 28, 2018 AForm 4 → | Mar 2, 5:25 pm EST | Jonathan ViolinSVP-Scientific Affairs & IR | 140,000 | — | — | 65,000 | — | |
| Feb 28, 2018 AForm 4 → | Mar 2, 5:24 pm EST | John M LimongelliSr. VP,General Counsel & CAO | 109,000 | — | — | 65,000 | — | |
| Feb 28, 2018 AForm 4 → | Mar 2, 5:23 pm EST | Yacoub HabibSVP, Bus Dev & Corp Planning | 109,000 | — | — | 65,000 | — | |
| Feb 28, 2018 AForm 4 → | Mar 2, 5:23 pm EST | David GeogheganSr. VP, Operations | 140,000 | — | — | 65,000 | — | |
| Feb 28, 2018 AForm 4 → | Mar 2, 5:22 pm EST | Roberto CucaSr. VP and CFO | 109,000 | — | — | 65,000 | — | |
| Feb 28, 2018 AForm 4 → | Mar 2, 5:21 pm EST | Carrie L. BourdowEVP & COO | 236,500 | — | — | 112,500 | — | |
| Feb 28, 2018 AForm 4 → | Mar 2, 5:20 pm EST | Maxine GowenPresident & CEO, Director | 402,500 | — | — | 252,500 | — | |
| Aug 28, 2017 AForm 4 → | Aug 29, 4:49 pm EDT | John M LimongelliSr. VP,General Counsel & CAO | 66,000 | — | — | 66,000 | — | |
| Aug 28, 2017 AForm 4 → | Aug 29, 4:48 pm EDT | Michael W. LarkSr. VP, Research & CSO | 66,000 | — | — | 66,000 | — | |
| Aug 28, 2017 AForm 4 → | Aug 29, 4:47 pm EDT | Yacoub HabibSVP, Bus Dev & Corp Planning | 66,000 | — | — | 66,000 | — | |
| Aug 28, 2017 AForm 4 → | Aug 29, 4:46 pm EDT | Roberto CucaSr. VP and CFO | 66,000 | — | — | 66,000 | — | |
| Aug 28, 2017 AForm 4 → | Aug 29, 4:45 pm EDT | Carrie L. BourdowSVP, Chief Commercial Officer | 66,000 | — | — | 66,000 | — | |
| Aug 28, 2017 AForm 4 → | Aug 29, 4:43 pm EDT | Maxine GowenPresident & CEO, Director | 225,000 | — | — | 225,000 | — | |
| May 17, 2017 AForm 4 → | Jun 6, 4:50 pm EDT | Jason Raleigh NunnDirector | 15,000 | — | — | 15,000 | — | late |
| May 17, 2017 AForm 4 → | Jun 6, 4:46 pm EDT | Barbara YanniDirector | 15,000 | — | — | 15,000 | — | late |
| May 17, 2017 AForm 4 → | Jun 6, 4:45 pm EDT | Anne M. PhillipsDirector | 15,000 | — | — | 15,000 | — | late |
| May 17, 2017 AForm 4 → | Jun 6, 4:44 pm EDT | Leon O Moulder Jr.Director | 15,000 | — | — | 15,000 | — | late |
| May 17, 2017 AForm 4 → | Jun 6, 4:43 pm EDT | Julie McHughDirector | 15,000 | — | — | 15,000 | — | late |
| May 17, 2017 AForm 4 → | Jun 6, 4:42 pm EDT | Adam KoppelDirector | 15,000 | — | — | 15,000 | — | late |
| May 17, 2017 AForm 4 → | Jun 6, 4:41 pm EDT | Michael R DoughertyDirector | 15,000 | — | — | 15,000 | — | late |
| Mar 2, 2017 AForm 4 → | Mar 3, 5:01 pm EST | David SoergelSr. VP,Clinical Dev. & CMO | 91,000 | — | — | 91,000 | — | |
| Mar 2, 2017 AForm 4 → | Mar 3, 5:00 pm EST | John M LimongelliSr. VP,General Counsel & CAO | 91,000 | — | — | 91,000 | — | |
| Mar 2, 2017 AForm 4 → | Mar 3, 4:59 pm EST | Michael W. LarkSr. VP, Research & CSO | 91,000 | — | — | 91,000 | — | |
| Mar 2, 2017 AForm 4 → | Mar 3, 4:59 pm EST | Yacoub HabibSVP, Bus Dev & Corp Planning | 91,000 | — | — | 91,000 | — | |
| Mar 2, 2017 AForm 4 → | Mar 3, 4:58 pm EST | Roberto CucaSr. VP and CFO | 113,750 | — | — | 113,750 | — | |
| Mar 2, 2017 AForm 4 → | Mar 3, 4:57 pm EST | Carrie L. BourdowSVP, Chief Commercial Officer | 91,000 | — | — | 91,000 | — | |
| Mar 2, 2017 AForm 4 → | Mar 3, 4:56 pm EST | Maxine GowenPresident & CEO, Director | 303,000 | — | — | 303,000 | — | |
| Feb 23, 2017 MForm 4 → | Feb 27, 8:34 am EST | Maxine GowenPresident & CEO, Director | 110,403 | — | — | 0 | — | |
| Feb 10, 2017 MForm 4 → | Feb 14, 5:20 pm EST | Michael W. LarkSr. VP, Research & CSO | 12,815 | — | — | 48,362 | — | |
| Jan 6, 2017 AForm 4 → | Jan 6, 4:49 pm EST | David SoergelSr. VP,Clinical Dev. & CMO | 55,000 | — | — | 55,000 | — | |
| Jan 6, 2017 AForm 4 → | Jan 6, 4:48 pm EST | John M LimongelliSr. VP,General Counsel & CAO | 55,000 | — | — | 55,000 | — | |
| Jan 6, 2017 AForm 4 → | Jan 6, 4:47 pm EST | Michael W. LarkSr. VP, Research & CSO | 55,000 | — | — | 55,000 | — | |
| Jan 6, 2017 AForm 4 → | Jan 6, 4:46 pm EST | Yacoub HabibSVP, Bus Dev & Corp Planning | 55,000 | — | — | 55,000 | — | |
| Jan 6, 2017 AForm 4 → | Jan 6, 4:44 pm EST | Roberto CucaSr. VP and CFO | 55,000 | — | — | 55,000 | — | |
| Jan 6, 2017 AForm 4 → | Jan 6, 4:43 pm EST | Carrie L. BourdowSVP, Chief Commercial Officer | 55,000 | — | — | 55,000 | — | |
| Jan 6, 2017 AForm 4 → | Jan 6, 4:42 pm EST | Maxine GowenPresident & CEO, Director | 175,000 | — | — | 175,000 | — | |
| May 18, 2016 AForm 4 → | May 19, 4:54 pm EDT | Barbara YanniDirector | 15,000 | — | — | 15,000 | — | |
| May 18, 2016 AForm 4 → | May 19, 4:54 pm EDT | Jason Raleigh NunnDirector | 15,000 | — | — | 15,000 | — | |
| May 18, 2016 AForm 4 → | May 19, 4:53 pm EDT | Anne M. PhillipsDirector | 15,000 | — | — | 15,000 | — | |
| May 18, 2016 AForm 4 → | May 19, 4:52 pm EDT | Leon O Moulder Jr.Director | 15,000 | — | — | 15,000 | — | |
| May 18, 2016 AForm 4 → | May 19, 4:52 pm EDT | Julie McHughDirector | 15,000 | — | — | 15,000 | — | |
| May 18, 2016 AForm 4 → | May 19, 4:51 pm EDT | Adam KoppelDirector | 15,000 | — | — | 15,000 | — | |
| May 18, 2016 AForm 4 → | May 19, 4:50 pm EDT | Michael R DoughertyDirector | 15,000 | — | — | 15,000 | — | |
| Mar 3, 2016 AForm 4 → | Mar 7, 5:07 pm EST | David SoergelSr. VP,Clinical Dev. & CMO | 105,000 | — | — | 105,000 | — | |
| Mar 3, 2016 AForm 4 → | Mar 7, 5:06 pm EST | John M LimongelliSr. VP,General Counsel & Secy | 118,750 | — | — | 118,750 | — | |
| Mar 3, 2016 AForm 4 → | Mar 7, 5:05 pm EST | Michael W. LarkSr. VP, Research & CSO | 118,750 | — | — | 118,750 | — | |
| Mar 3, 2016 AForm 4 → | Mar 7, 5:03 pm EST | Yacoub HabibSVP, Bus Dev & Corp Planning | 95,000 | — | — | 95,000 | — | |
| Mar 3, 2016 AForm 4 → | Mar 7, 5:02 pm EST | Roberto CucaSr. VP and CFO | 95,000 | — | — | 95,000 | — | |
| Mar 3, 2016 AForm 4 → | Mar 7, 5:01 pm EST | Carrie L. BourdowSVP, Chief Commercial Officer | 95,000 | — | — | 95,000 | — | |
| Mar 3, 2016 AForm 4 → | Mar 7, 5:00 pm EST | Maxine GowenPresident & CEO, Director | 350,000 | — | — | 350,000 | — | |
| Jul 20, 2015 AForm 4 → | Jul 21, 5:42 pm EDT | Yacoub HabibSVP, Bus Dev & Corp Planning | 125,000 | — | — | 125,000 | — | |
| May 20, 2015 AForm 4 → | May 21, 4:48 pm EDT | Jason Raleigh NunnDirector | 8,870 | — | — | 8,870 | — | |
| May 20, 2015 AForm 4 → | May 21, 3:23 pm EDT | Barbara YanniDirector | 8,870 | — | — | 8,870 | — | |
| May 20, 2015 AForm 4 → | May 21, 3:20 pm EDT | Anne M. PhillipsDirector | 8,870 | — | — | 8,870 | — | |
| May 20, 2015 AForm 4 → | May 21, 3:18 pm EDT | Francois NaderDirector | 8,870 | — | — | 8,870 | — | |
| May 20, 2015 AForm 4 → | May 21, 3:16 pm EDT | Leon O Moulder Jr.Director | 8,870 | — | — | 8,870 | — | |
| May 20, 2015 AForm 4 → | May 21, 3:14 pm EDT | Julie McHughDirector | 8,870 | — | — | 8,870 | — | |
| May 20, 2015 AForm 4 → | May 21, 3:06 pm EDT | Adam KoppelDirector | 8,870 | — | — | 8,870 | — | |
| May 20, 2015 AForm 4 → | May 21, 2:57 pm EDT | Michael R DoughertyDirector | 8,870 | — | — | 8,870 | — | |
| May 4, 2015 AForm 4 → | May 5, 10:54 am EDT | Carrie L. BourdowSVP, Chief Commercial Officer | 125,000 | — | — | 125,000 | — | |
| Mar 17, 2015 AForm 4 → | Mar 19, 5:24 pm EDT | John M LimongelliSr. VP,General Counsel & Secy | 70,000 | — | — | 70,000 | — | |
| Mar 17, 2015 AForm 4 → | Mar 19, 5:22 pm EDT | Roberto CucaSr. VP and CFO | 70,000 | — | — | 70,000 | — | |
| Mar 17, 2015 AForm 4 → | Mar 19, 5:19 pm EDT | David SoergelSr. VP,Clinical Dev. & CMO | 87,500 | — | — | 87,500 | — | |
| Mar 17, 2015 AForm 4 → | Mar 19, 5:17 pm EDT | Michael W. LarkSr. VP, Research & CSO | 87,500 | — | — | 87,500 | — | |
| Mar 17, 2015 AForm 4 → | Mar 19, 5:14 pm EDT | Maxine GowenPresident & CEO, Director | 300,000 | — | — | 300,000 | — |